Literature DB >> 26319839

[DIETARY INTAKE AND NUTRITIONAL STATUS IN ONCOLOGY PATIENTS WHO START TREATMENT WITH TYROSINE KINASE INHIBITORS].

Isabel Higuera-Pulgar1, Almudena Ribed2, M Luisa Carrascal-Fabian1, Irene Bretón-Lesmes1, Rosa M Romero-Jiménez2, Cristina Cuerda-Compes1, Cristina Velasco-Gimeno1, Miguel Camblor-Álvarez1, Pilar García-Peris1.   

Abstract

BACKGROUND: in recent years, researching about new oral antineoplastics has progressed while its impact on dietary intake and nutritional status (NS) hasn't developed enough yet.
OBJECTIVES: dietary intake and NS assessment in patients who start treatment with tyrosine kinase inhibitors (TKI) and evaluate its impact on them.
METHODS: an observational, prospective-six-months study, in which were included patients starting treatment with TKI. The intake was evaluated by a 24 h dietary record and a food frequency questionnaire. The NS was evaluated by anthropometric measurements and the patient-generated Global Subjective Assessment (PG-GSA); the results were compared with the Spanish references (SENC-semFYC, 2007 and O. Moreiras, 2013). Friedman test, χ2, Wilcoxon, Kruskal-Wallis and Mann-Whitney were used in the statistical analysis. Significance p < 0.05.
RESULTS: 22 patients (54.5% male) were included. At baseline, NS was adequate in 73.9% of patients according PG-GSA. Weight loss was no significant, although a high percentage of the energy and protein requirements hadn't been reached. The caloric intake was positively related with the number of meals. Dietary habits did not change during treatment.
CONCLUSION: dietary intake did not reach nutritional requirements at baseline. The TKI don't seem to affect the patient's intake and nutritional status. The research about these parameters before starting treatment could prevent future complications and it would guide the dietary advice. Copyright AULA MEDICA EDICIONES 2014. Published by AULA MEDICA. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26319839     DOI: 10.3305/nh.2015.32.3.9315

Source DB:  PubMed          Journal:  Nutr Hosp        ISSN: 0212-1611            Impact factor:   1.057


  2 in total

1.  Impact of the antifermentative diet during radiotherapy for prostate cancer in elderly, SÃO Paulo, Brazil.

Authors:  Érica Line de Oliveira Pedron; Rita de Cássia de Aquino; Claudia Borin da Silva
Journal:  Support Care Cancer       Date:  2019-11-27       Impact factor: 3.603

2.  The effect of chemotherapy on dietary intake and nutritional status in patients with colorectal neoplasms and the importance of nutritional counseling.

Authors:  Jessica Sillas de Freitas; Érica Line de Oliveira Pedron; Joyce de Lima E Silva Aliprandi; Gilberto Cândido Laurentino; Ana Lucia Gatti; Nora Manoukian Forones; Rita de Cássia de Aquino
Journal:  Support Care Cancer       Date:  2022-01-18       Impact factor: 3.603

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.